Subject category:
Strategy and General Management
Published by:
Harvard Business Publishing
Version: 17 May 1994
Length: 25 pages
Data source: Field research
Share a link:
https://casecent.re/p/46111
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Genzyme Corp, one of the largest biotechnology companies, has succeeded in developing, manufacturing, and commercializing its first therapeutic, a treatment for a rare genetic disease. Analysis of the case requires students to identify and understand how Genzyme has designed its strategy to effectively manage, mitigate, or exploit the uncertainties it had faced in the past. In 1993, the company faces challenges in managing future uncertainties involving the product's market, manufacturing, and pricing.
Location:
Industry:
Size:
USD220 million revenues, 1,500 employees
Other setting(s):
1993
Subject category:
Strategy and General Management
Published by:
Harvard Business Publishing
Length: 21 pages
About
Abstract
Genzyme Corp, one of the largest biotechnology companies, has succeeded in developing, manufacturing, and commercializing its first therapeutic, a treatment for a rare genetic disease. Analysis of the case requires students to identify and understand how Genzyme has designed its strategy to effectively manage, mitigate, or exploit the uncertainties it had faced in the past. In 1993, the company faces challenges in managing future uncertainties involving the product's market, manufacturing, and pricing.
Settings
Location:
Industry:
Size:
USD220 million revenues, 1,500 employees
Other setting(s):
1993
Related
Subject category:
Strategy and General Management
Published by:
Harvard Business Publishing
Length: 21 pages